PhaseRx, Inc.
PZRXQ
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -56.61% | -46.49% | 642.06% | 798.31% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.13% | -9.65% | 199.14% | 196.52% | -- |
| Operating Income | 22.13% | 9.65% | -199.14% | -215.67% | -- |
| Income Before Tax | 26.59% | 17.37% | -168.94% | -172.98% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 26.59% | 17.37% | -168.94% | -172.98% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.59% | 17.37% | -168.94% | -172.98% | -- |
| EBIT | 22.13% | 9.65% | -199.14% | -215.67% | -- |
| EBITDA | 21.85% | 9.03% | -209.91% | -232.27% | -- |
| EPS Basic | 88.74% | 91.11% | 81.93% | 53.26% | -- |
| Normalized Basic EPS | 88.74% | 91.11% | 81.93% | 53.26% | -- |
| EPS Diluted | 88.74% | 91.11% | 81.93% | 53.26% | -- |
| Normalized Diluted EPS | 88.74% | 91.11% | 81.93% | 53.26% | -- |
| Average Basic Shares Outstanding | 149.12% | 514.37% | 1,829.69% | 1,342.22% | -- |
| Average Diluted Shares Outstanding | 149.12% | 514.37% | 1,829.69% | 1,342.22% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |